Showing results (1651-1660 of 2,020) with videos related to
Sort By:
Pageof 202
Orvosi Hetilap|March 18, 2008
[Investigation of redox homeostasis in liver and renal transplant recipients]Eniko Sárváry, Balázs Nemes, Zsuzsa Gerlei, et al.International Journal of Molecular Sciences|March 13, 2024
Clinical and Molecular Characterization of Nine Novel Antithrombin MutationsJudit Kállai, Réka Gindele, Krisztina Pénzes-Daku, et al.Frontiers in Endocrinology|September 4, 2023
A three-month physical training program improves cardiovascular autonomic function in patients with metabolic syndrome with and without diabetes - a pilot studyAnna Vágvölgyi, Judit Erzsébet Ábrahám, Éva Máthéné Köteles, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 7, 2022
Physiological and transcriptional profiling of surfactin exerted antifungal effect against Candida albicansÁgnes Jakab, Fruzsina Kovács, Noémi Balla, et al.Nucleic Acids Research|March 24, 2020
Spatially regulated editing of genetic information within a neuronIsabel C Vallecillo-Viejo, Noa Liscovitch-Brauer, Juan F Diaz Quiroz, et al.Computational and Structural Biotechnology Journal|June 30, 2025
SurvSig: Harnessing gene expression signatures to uncover heterogeneity in lung neuroendocrine neoplasmsKolos Nemes, Gabriella Mihalekné Fűr, Alexandra Benő, et al.The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 21, 2008
Contrast-enhanced three-dimensional dobutamine stress echocardiography: between Scylla and Charybdis?Boudewijn J Krenning, Attila Nemes, Osama I I Soliman, et al.Plos One|April 28, 2015
Increased Short-Term Beat-To-Beat Variability of QT Interval in Patients with AcromegalyAndrea Orosz, Éva Csajbók, Csilla Czékus, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2009
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIIIM Recht, L Nemes, M Matysiak, et al.Pageof 202